REAL-WORLD OUTCOMES IN DAILY TERIPARATIDE PATIENTS IN JAPAN

被引：0
|
作者：
Burge, R. [1 ]
Sato, M. [2 ]
Sugihara, T. [3 ]
机构：
[1] Eli Lilly & Co, Global Hlth Outcomes, Indianapolis, IN 46285 USA
[2] Eli Lilly Japan KK, Hlth Outcomes & Hlth Technol Assessment, Kobe, Hyogo, Japan
[3] inVentiv Hlth Clin, Princeton, NJ USA
来源：
OSTEOPOROSIS INTERNATIONAL | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P738
引用
收藏
页码：S407 / S407
页数：1
相关论文
共 50 条
  • [1] Real-world clinical and economic outcomes for daily teriparatide patients in Japan
    Burge, Russel
    Sato, Masayo
    Sugihara, Tomoko
    [J]. JOURNAL OF BONE AND MINERAL METABOLISM, 2016, 34 (06) : 692 - 702
  • [2] Real-world clinical and economic outcomes for daily teriparatide patients in Japan
    Russel Burge
    Masayo Sato
    Tomoko Sugihara
    [J]. Journal of Bone and Mineral Metabolism, 2016, 34 : 692 - 702
  • [3] REAL-WORLD TREATMENT PATTERNS AMONG DAILY TERIPARATIDE PATIENTS IN JAPAN
    Sato, M.
    Burge, R.
    Sugihara, T.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2014, 25 : 640 - 641
  • [4] Real-world treatment outcomes among patients with metastatic pancreatic cancer in Japan: The Tokushukai real-world data project
    Shimoyama, Rai
    Imamura, Yoshinori
    Uryu, Kiyoaki
    Mase, Takahiro
    Fujimura, Yoshiaki
    Hayashi, Maki
    Ohtaki, Megu
    Ohtani, Keiko
    Shinozaki, Nobuaki
    Minami, Hironobu
    [J]. MOLECULAR AND CLINICAL ONCOLOGY, 2023, 19 (06)
  • [5] Real-World DMARD Experience and Outcomes for Rheumatoid Arthritis Patients in Japan: Safety
    Kishimoto, Mitsumasa
    Tanaka, Yoshiya
    Harrold, Leslie
    Onofrei, Alina
    Barr, Christine
    Agarwal, Ekta
    Rivas, Jose L.
    Sugiyama, Naonobu
    Greenberg, Jeffrey
    Yamanaka, Hisashi
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [6] Real-World DMARD Experience and Outcomes for Rheumatoid Arthritis Patients in Japan: Effectiveness
    Tanaka, Yoshiya
    Yamanaka, Hisashi
    Harrold, Leslie
    Lin, Tin-chi
    Agarwal, Ekta
    Rivas, Jose L.
    Sugiyama, Naonobu
    Greenberg, Jeffrey
    Kishimoto, Mitsumasa
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [7] Real-world use of apremilast for patients with psoriasis in Japan
    Kishimoto, Megumi
    Komine, Mayumi
    Hioki, Tomoyuki
    Kamiya, Koji
    Sugai, Junichi
    Ohtsuki, Mamitaro
    [J]. JOURNAL OF DERMATOLOGY, 2018, 45 (11): : 1345 - 1348
  • [8] Real-world treatment outcomes of metastatic biliary tract cancer patients in Japan: the Tokushukai REAl-world data project 04 (TREAD 04)
    Shimoyama, Rai
    Imamura, Yoshinori
    Uryu, Kiyoaki
    Mase, Takahiro
    Taguri, Masataka
    Okuda, Tadahisa
    Fujimura, Yoshiaki
    Hayashi, Maki
    Tanaka, Satomi
    Sawamukai, Keiji
    Minami, Hironobu
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (01) : 70 - 80
  • [9] Real-world effectiveness of daily teriparatide in Japanese patients with osteoporosis at high risk for fracture: final results from the 24-month Japan Fracture Observational Study (JFOS)
    Soen, Satoshi
    Fujiwara, Saeko
    Takayanagi, Ryoichi
    Kajimoto, Kenta
    Tsujimoto, Mika
    Kimura, Shuichi
    Sato, Masayo
    Krege, John H.
    Enomoto, Hiroyuki
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (11) : 2049 - 2056
  • [10] Real-world outcomes of siponimod in multiple sclerosis patients
    Tan, Hongmei
    Quan, Chao
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 1129 - 1129
12345